Sponsor:
Prelude Therapeutics
Code:
NCT05665530
Conditions
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Mantle Cell Lymphoma (MCL)
Richter's Syndrome
T-cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PRT2527
Zanubrutinib
Venetoclax
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations